Microarray studies indicated that BRAF-mutant tumors have a unique mRNA expression profile compared to EGFR- and IDH1-mutant tumors, with upregulation of genes related to immune tolerance and invasion, suggesting a unique mechanism for tumorigenesis in this subset of GBM. The gene discussed is IDH1; the disease is glioblastoma.